Contract Option Exercises — April 08, 2026

Shionogi's $119M cost-plus-fixed-fee award (potential $482M with options) for antibiotics against biothreat pathogens provides 10-year revenue visibility through 2036, though $0 outlayed signals early-stage execution.

ManTech Advanced Systems' cost-plus-award-fee contract obligated $77M with a $910M ceiling through potential 2032 end supports cyber enterprise services, bolstering ManTech's defense-adjacent IT exposure via GSA vehicle.

Salient CRGT's $93M time-and-materials award (potential $199M) with $22M outlayed already underscores VA tech acquisition momentum in computer systems design through 2030.

IBM's second Treasury win obligates $90M (potential $148M) firm-fixed-price for IT services with $51M outlayed, adding to its $110M prior IRS contract and signaling sustained IRS IT modernization demand.

IBM's $110M fully outlayed Treasury delivery order was terminated for convenience on 3/24/2025 per executive orders, despite original 2024 end date, capping future revenue.

Smartronix's $116M obligation (potential $165M) under GSA has -$162k outlayed despite $59M subawards, on a 2018-2023 contract now expired, limiting forward revenue.

Multiple high-materiality awards like Shionogi $119M HHS and ManTech $77M GSA show $0 outlays, delaying revenue recognition amid firm-fixed-price prevalence (e.g., Quality Support $113M State).

IBM's $110M Treasury contract terminated 3/24/2025 per executive orders highlights civilian IT vulnerability to policy shifts.

Smartronix $116M GSA IT award expired 2023-08-04 with negative outlays, risking non-renewal or re-compete.

IBM holds $200M+ in Treasury/IRS IT obligations across two contracts, exposing to agency-specific cuts.

HHS/BARDA biotech R&D awards to Shionogi $119M and Vedanta $79M (70% outlayed) signal multi-year biothreat funding through 2031+.

ManTech's $77M GSA cyber IT (up to $910M ceiling) for USSOUTHCOM offers scalable revenue to 2032.

VA IT awards cluster: Salient CRGT $93M, Greenbrier $61M (90% outlayed), GD $65M highlight tech acquisition center spending.

Shionogi $119M and Vedanta $79M awards fund late-stage antibiotics development for drug-resistant infections through 2036/2031, with cost-sharing structures.

IBM $200M+ Treasury, Salient $93M VA, ManTech $77M GSA, Deloitte $70M State awards emphasize NAICS 541512 systems design across IRS, VA, State.

Three VA awards totaling $219M (Salient $93M, GD $65M, Greenbrier $61M) focus on IT platforms, computing infrastructure, software maintenance.

{"entity"=>"ManTech International (MANT)", "reason"=>"$77M GSA USSOUTHCOM cyber IT with $910M ceiling but $0 outlayed and $161M subawards.", "trigger"=>"option exercises beyond 2026-04-24 current end"}

{"entity"=>"IBM (IBM)", "reason"=>"$90M new IRS award + $110M terminated contract; track outlays and settlements.", "trigger"=>"Treasury FY2026 budget and termination settlement from 3/24/2025"}

{"entity"=>"Shionogi Inc", "reason"=>"$119M HHS BARDA biotech with $482M potential but $0 outlayed over 10 years.", "trigger"=>"initial outlay progress and FDA milestones"}

{"entity"=>"Salient CRGT", "reason"=>"$93M VA IT with $22M outlayed toward $199M ceiling through 2030.", "trigger"=>"option exercises post-2027-04-10"}